IP Library › Granted Patent US 12,327,356
Granted Patent B2
US 12,327,356 · App. 18/754,934 · Granted Jun 10, 2025

Methods of assessing lung disease in chest X-rays

Inventor: Richard Vlasimsky (Denver, CO)
Assignee: IMIDEX, INC.
G06T7/0012A61B6/50A61B6/5217G06N3/045G06T3/40G06T7/11G06V10/764G06V10/82G16H30/40G16H50/20G06T2207/10116G06T2207/20076G06T2207/20081G06T2207/20084G06T2207/30061G06T2207/30096G06T2207/30168G06V2201/032
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,327,356
App. No.
18/754,934
Granted
Jun 10, 2025
Kind
B2
Abstract

The present system provides methods and systems of detecting lung abnormalities in chest x-ray images using at least two neural networks.

Claims (15)

1. A diagnostic method, the method comprising: providing an image file of a chest x-ray from a patient to a machine learning system that has been trained on training data only available at a plurality of sources separated by time and/or geography and the training comprises connecting the machine learning system to the plurality of sources at different times and/or locations, wherein the machine learning system operates by resizing the image file of the chest x-ray into a first image that depicts the entire x-ray at a reduced resolution and placing a subsection of the file into a second image at an original resolution; analyzing the first and second images in parallel by respective first and second neural networks to output scores indicating a probability of a nodule, wherein the machine learning system has been trained to learn associations between features in chest x-rays and known pathology results with an area under the curve (AUC) of true positives over false positives for learned feature associations is between 0.7 and 0.83; and operating the machine learning system to detect lung nodules.

2. The method of claim 1 , wherein connecting the machine learning system to the plurality of sources provides a federated learning model by which patient data does not leave any of the plurality of sources.

3. The method of claim 2 , wherein the machine learning system comprises a plurality of distributed machine learning (ML) subsystems using a federated learning model to provide the machine learning system trained to detect abnormalities in chest x-rays.

4. The method of claim 1 , wherein the machine learning system is further trained on CT scans from the subjects to affirm or negate learned feature associations.

5. The method of claim 4 , wherein the CT scans are obtained as diverse CT scans from different instruments operating under diverse imaging conditions or parameters, the method further comprising reconstructing a standardized CT scan from each of the diverse CT scans.

6. The method of claim 5 , wherein the system includes a GAN trained to reconstruct standardized CT scans from the diverse CT scans and to augment the training data to make the neural networks generalizable across a plurality of image acquisition equipment and parameters.

7. The method of claim 1 , wherein the AUC≥0.74 is achieved by unsupervised learning without the aid of human once the learning is initiated.

8. The method of claim 1 , further comprising a human-in-loop training step that includes: displaying the chest x-ray to a clinician;

receiving at the machine learning system an annotation from the clinician that identifies a lung nodule in the chest x-ray;

comparing by the machine learning system the annotation to one of the scores indicating a probability of a nodule; and

using the comparison to improve learned feature associations.

9. The method of claim 1 , further comprising the machine learning system providing an alert that the system detected an abnormality in the chest x-ray from the subject and/or providing a region proposal including the abnormality in the chest x-ray.

10. The method of claim 9 , further comprising triaging the chest x-ray for immediate review by a human.

11. The method of claim 1 , further comprising characterizing an identified lung nodule with the machine learning system.

12. The method of claim 11 , wherein characterizing includes: classifying a nodule as a tumor, benign and/or malignant, and/or assessing or predicting nodule progression, volumetric sizing, nodule etiology, nodule histology, and/or response to treatment.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2026
From: IMIDEX INC.
To: DEEPHEALTH, INC.
Reel/Frame 074254/0837 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2024
From: VLASIMSKY, RICHARD
To: IMIDEX, INC.
Reel/Frame 068393/0872 →
Continuity (3)
Continuation 17545383 · Dec 8, 2021
Provisional Application 63123183 · Dec 9, 2020
Related Publication 20240346654A1 · Oct 17, 2024
References Cited (2)
US 20200372650A1 · Furukawa · 2020 [cited by examiner]
US 20210265043A1 · Haghighi · 2021 [cited by examiner]